DUBLIN--(BUSINESS WIRE)--The "Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The global oxidative stress assay market for pharmaceutical industry to grow at a CAGR of 8.36% during the period 2018-2022.
Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one driver in the market is increasing investments in drug discovery. Oxidative stress determines the imbalance in the production of free radicals and the ability of cells to detoxify harmful effects by using antioxidants to neutralize the radicals. As a result, pharmaceutical companies are investing significantly in developing drugs that act as antioxidants to minimize the damage caused by free radicals.
One trend in the market is outsourcing drug discovery processes. Oxidative stress assay tests are mainly outsourced to CROs and CMOs to ensure the availability of safe and stress-free environment. With the growing emphasis on R&D investments and drug discovery, companies are preferring to outsource drug discovery processes such as oxidative stress assays and other pharmaceutical tests.
- Promega Corporation
- Thermo Fisher Scientific
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Market Sizing
Part 06: Five Forces Analysis
Part 07: Market Segmentation By Product
Part 08: Customer Landscape
Part 09: Regional Landscape
Part 10: Decision Framework
Part 11: Drivers And Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Vendor Analysis
Part 15: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/3w44w9/global_oxidative?w=4